Prospective Registration of all Patients in a Geographical Region with Newly Diagnosed Bladder Carcinomas during a Two-year Period

REFERENCES

• Malmström P-U, Thorn M, Lindblad P, Bergstrom R, Adami H-0. Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960–1989. Eur J Cancer 1993; 29A: 1868–72.
   Google Scholar
• Kiemeney LALM, Coebergh JWVV, Koper NP, Van der Heijden LH, Pauwels RPE, Schapers RFM, et al. Bladder cancer incidence and survival in the South-Eastern part of the Netherlands. Eur J Cancer 1994; 30A: 1134–7.
   Google Scholar
• Anderström C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 1980; 124: 23–6.
   Google Scholar
• Malmström P-U, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. Scand J Urol Nephrol 1987; 21: 185–95.
   PubMedGoogle Scholar
• Fossa SD, Ous S, Espetveit S, Langmark F. Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer. Scand J Urol Nephrol 1992; 26: 131–8.
   PubMed Web of Science ®Google Scholar
• Miller A, Mitchell JP, Brown NJ. The Bristol bladder tumour registry. Br J Urol 1969; Suppl 41: 1–64.
   Google Scholar
• Wolf H, Rosenkilde Olsen P, Fischer A, Hojgaard K. Urothelial atypia concomitant with primary bladder tumour. Incidence in a consecutive series of 500 unselected patients. Scand J Urol Nephrol 1987; 21: 33–8.
   PubMed Web of Science ®Google Scholar
• Lipponen P. The changing importance of prognostic factors in bladder cancer during a long-term follow-up. Eur J Cancer 1993; 29A: 1261–5.
   PubMed Web of Science ®Google Scholar
• Anderström C, Johansson SL, Nilsson S. Carcinoma of the urinary bladder: diagnosis and treatment. Regional treatment program Oncology Centre, Goteborg, 1986 (In Swedish).
   Google Scholar
• Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International histological classification of tumours, No. 10. Geneva: World Health Organisation, 1973.
   Google Scholar
• Harmer MH, editor. UICC TNM classification of malignant tumours. 3rd ed. Geneva: International Union Against Cancer, 1978.
   Google Scholar
• Lynch CF, Platz CE, Jones MP, Gazzaniga M. Cancer registry problems in classifying invasive bladder cancer. J Natl Cancer Inst 1991; 83: 429–33.
   PubMedGoogle Scholar
• Hellsten S, Glifberg I, Lindholm C-E, Telhammar E. Therapy of bladder carcinoma. Scand J Urol Nephrol 1981; 15: 115–20.
   PubMed Web of Science ®Google Scholar
• Dickinson AJ, Howe K, Bedford C, Sanders T, Prentice A, Sibley GNA. A retrospective study of the investiga-tion and management of muscle-invasive bladder cancer in the South West Region. Br J Urol 1996; 77: 70–5.
   PubMedGoogle Scholar
• Kiemeney LALM, Witjes JA, Verbeek ALM, Heijbroek RP, Debruyne FMJ and members of the Dutch South-East Cooperative Urological Group. The clinical epidemiology of superficial bladder cancer. Br J Cancer 1993; 67: 806–12.
   PubMed Web of Science ®Google Scholar
• Cohen HJ. Biology of aging as related to cancer. Cancer 1994; 74: 2092–100.
   PubMed Web of Science ®Google Scholar
• See WA, Fuller JR. Staging of advanced bladder cancer. Urol Clin North Am 1992; 19: 663–83.
   PubMed Web of Science ®Google Scholar
• Abel PD, Henderson D, Bennett MK, Hall RR, Williams G. Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol 1988; 62: 339–42.
   Google Scholar
• Bochner BH, Nichols PW, Skinner DG. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder. Urology 1995; 45: 528–31.
   Google Scholar
• Anderström C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopatho-logic and prognostic study. Cancer 1983; 52: 1273–80.
   Google Scholar
• Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992; 6: 1–30.
   PubMed Web of Science ®Google Scholar
• Kiemeney LALM, Witjes JA, Heijbroek RP, Koper NP, Verbeek ALM, Debruyne FMJ, and the members of the Dutch South-East Cooperative Urological Group. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol 1994; 73: 164–71.
   Google Scholar
• Sakamoto N, Tsuneyoshi M, Naito S, Kumazawa J. An adequate sampling of the prostate to identify pro static involvement by urothelial carcinoma in bladder cancer patients. J Urol 1993; 149: 318–21.
   PubMed Web of Science ®Google Scholar
• Solsona E, Iborra I, Ricos JV, Monros JL, Casanova JL, Almenar S. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol 1995; 154: 1710–3.
   PubMed Web of Science ®Google Scholar
• Larsen MP, Steinberg GD, Brendler CB, Epstein JI. Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion. Mod Pathol 1990; 3: 83–8.
   PubMed Web of Science ®Google Scholar
• Prout GR, Barton BA, Griffin PP, Friedell GHand the National Cancer Group. Treated history of non-invasive grade 1 transitional cell carcinoma. J Urol 1992; 148: 1413–9.
   Google Scholar
• Epstein JI, Amin MB, Reuter VR, Mostofi FK and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transi-tional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435–48.
   Google Scholar
• Witjes JA, Kiemeney LALM, Schaafsma HE, Debruyne FMJ and the Members of the Dutch South-East Cooperative Urological Group. The influence of review pathology on study outcome of a randomized multi-centre superficial bladder cancer trial. Br J Urol 1994; 73: 172–6.
   Google Scholar